Skip to main content
. Author manuscript; available in PMC: 2010 Aug 15.
Published in final edited form as: Cancer Res. 2009 Aug 4;69(16):6546–6555. doi: 10.1158/0008-5472.CAN-09-0605

Figure 1. BCR-ABL inhibits the protein expression of FoxO3a.

Figure 1

a) Western blot indicates decreased FoxO3a expression in BCR-ABL expressing BaF3 cells. Values below the blot are determined by densitometry with β-ACTIN normalization. p-FoxO3a, BCR-ABL, and β-ACTIN are included as controls. b) Western blot of whole cell lysates from vector or BCR-ABL-transduced primary murine bone marrow cells showing a similar pattern of FoxO3a expression as in a.